Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAW039 in inadequately controlled asthma
NCT01836471Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of fevipiprant in asthma, sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
fevipiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01836471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836471.